See the DrugPatentWatch profile for Linzess
The price of Linzess 290 mg can vary depending on factors such as insurance coverage, pharmacy, and whether a coupon or discount is applied.
What influences the cost of Linzess 290 mg?
The retail price for a 30-day supply of Linzess 290 mcg can range from approximately $400 to $500, though actual out-of-pocket costs for patients often differ significantly due to insurance plans. Many individuals with commercial insurance may pay between $30 and $100 per month for Linzess, especially when utilizing manufacturer coupons or savings cards [1]. For those without insurance or with high deductibles, the cost can be considerably higher.
How can I find cheaper options for Linzess 290 mg?
Patients seeking to reduce the cost of Linzess 290 mg can explore several avenues. The manufacturer, AbbVie, offers a Linzess Savings Card for eligible commercially insured patients, which can lower co-pays to as little as $30 for a 30-day supply [1]. Discount pharmacies or prescription discount cards may also offer savings. Comparing prices across different pharmacies is advisable, as pricing can fluctuate. For those who do not qualify for savings programs, generic alternatives are not yet available, as the drug's patent protection is still active.
When does the Linzess patent expire?
Linzess (linaclotide) has patent protection that influences its pricing and the availability of generics. The earliest key patent for Linzess is set to expire around 2028, though other related patents may extend further [2]. Until patent expiration, the drug remains under patent protection, limiting the market entry of generic versions.
Can I get Linzess 290 mg if I have Medicare or Medicaid?
Coverage and cost for Linzess 290 mg under Medicare and Medicaid can vary. Medicare Part D plans may cover Linzess, but co-pays will depend on the specific plan's formulary and tiering. Medicaid programs also have their own formularies and eligibility requirements. Patients should consult their specific Medicare or Medicaid plan details and discuss options with their healthcare provider and pharmacist regarding prescription coverage.
What are the alternatives to Linzess for IBS-C?
For individuals with Irritable Bowel Syndrome with Constipation (IBS-C), several alternative medications exist, each with different mechanisms of action and potential side effects. These may include other prescription medications like Amitiza (lubiprostone) or Trulance (plecanatide), which also work to increase fluid secretion in the intestines. Over-the-counter options like fiber supplements (e.g., psyllium) and osmotic laxatives (e.g., polyethylene glycol) are also commonly used. The choice of alternative often depends on the severity of symptoms, individual patient response, and tolerance for side effects.
What clinical data supports Linzess 290 mg effectiveness?
Clinical trials have demonstrated the efficacy of Linzess in treating IBS-C and chronic idiopathic constipation. Studies have shown that Linzess can significantly increase the frequency of bowel movements and reduce abdominal pain and discomfort in patients [3]. The 290 mcg dosage is typically prescribed for IBS-C.
Sources:
1. https://www.drugpatentwatch.com/drug/linzess/savings-programs
2. https://www.drugpatentwatch.com/drug/linzess/patents
3. https://www.drugpatentwatch.com/drug/linzess/clinical-trials